Where does Kim Kamdar work?

Kim Kamdar is Managing Partner at Medical Excellence Capital and Board director at Evofem Biosciences and Board director at Tragara Pharmaceuticals.

What boards does Kim Kamdar sit on?

Kim Kamdar holds tracked board seats at Evofem Biosciences, Tragara Pharmaceuticals.

Kim Kamdar

Investor

Managing Partner at Medical Excellence Capital · Partner at Domain Associates · Board director at Evofem Biosciences · Board director at Tragara Pharmaceuticals

San Diego, California, United States

About

Kim Kamdar, a former Novartis research director and repeat founding CEO (Truvian Sciences, Seraphina Therapeutics), quietly co-founds companies, moves to Chair, and advances global health via Adjuvant Capital.

Contact· self-published, not guessed

k•••@medexcelcap.comreveal

Invests in

AI & Machine LearningBiotechHealthtechMedical Devices

Board director at Evofem Biosciences

Intro paths

→

In turn, Kim can intro founders to Evofem Biosciences's investors below.

Evofem Biosciences's investors · 1

Domain AssociatesPrinceton · $200K – $15M checks · since 2020

Board director at Tragara Pharmaceuticals

Intro paths

→

In turn, Kim can intro founders to Tragara Pharmaceuticals's investors below.

Tragara Pharmaceuticals's investors · 1

Domain AssociatesPrinceton · $200K – $15M checks · since 2015

Experience

Medical Excellence Capital, LLCManaging Partnercurrent2021 — presentSan Diego, California, United States
Domain AssociatesPartnercurrent2005 — present

Deals · 2

Evofem BiosciencesBoard seat

via Domain Associates · filed May 2020 · $25M raise

Tragara PharmaceuticalsBoard seat

via Domain Associates · filed Jul 2015 · $1.2M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Medical Excellence Capital

Annabel Stoddart

Office Manager and Executive Assistant at Medical Excellence Capital

Brad Ringeisen

Scientific Advisory Board – Executive Director of Innovative Genomics Institute at Medical Excellence Capital

Brian Halak

Managing Partner at Medical Excellence Capital

Douglas Wallace

Scientific Advisory Board – Director of Center for Mitochondrial and Epigenomic Medicine at Medical Excellence Capital

Eric Heil

Managing Partner at Medical Excellence Capital

Gregg Semenza

Scientific Advisory Board – Professor at Johns Hopkins at Medical Excellence Capital

John Hornbostel

Counsel at Medical Excellence Capital

John Prufeta

Chief Executive Officer and Managing Partner at Medical Excellence Capital

Network2

Brian Dovey

Partner at Domain Associates

Dennis Podlesak

Venture Partner at Domain Associates

Investors connected to Kim in public investor directories — a warm-intro map.

Frequently asked questions

Who is Kim Kamdar?: Kim Kamdar, a former Novartis research director and repeat founding CEO (Truvian Sciences, Seraphina Therapeutics), quietly co-founds companies, moves to Chair, and advances global health via Adjuvant Capital.
Where does Kim Kamdar work?: Kim Kamdar is Managing Partner at Medical Excellence Capital and Board director at Evofem Biosciences and Board director at Tragara Pharmaceuticals.
What does Kim Kamdar invest in?: Kim Kamdar invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
What boards does Kim Kamdar sit on?: Kim Kamdar holds tracked board seats at Evofem Biosciences, Tragara Pharmaceuticals.